09:01 AM EDT, 10/10/2024 (MT Newswires) -- US equity futures were cautiously lower ahead of Thursday's opening bell as traders digested the consumer inflation report.

Dow Jones Industrial Average futures slipped 0.2%, S&P 500 futures declined 0.3% and Nasdaq futures were down 0.4%.

Oil prices were higher, with front-month global benchmark North Sea Brent crude up 1.3% at $77.56 per barrel and US West Texas Intermediate crude up 1.3% at $74.22 per barrel.

Consumer prices, released at 8:30 am ET, rose 0.2% in September to match the prior month's increase, compared with estimates compiled by Bloomberg for a smaller 0.1% gain. Core prices rose 0.3%, also matching August's gain and higher than estimates for a 0.2% increase.

New unemployment claims rose to 258,000 in the week ended Oct. 5 from 225,000 in the preceding week, compared with estimates for 230,000 claims.

In other world markets, Japan's Nikkei closed 0.3% higher, Hong Kong's Hang Seng ended 3% higher, and China's Shanghai Composite finished 1.3% higher. Meanwhile, UK's FTSE 100 slipped 0.05%, and Germany's DAX index fell 0.1% in Europe's early afternoon session.

In equities, shares of Tempest Therapeutics ( TPST ) were 25% higher pre-bell after the company secured a deal with Roche to advance a treatment candidate for a form of liver cancer and extended a limited duration shareholder rights plan. GXO Logistics ( GXO ) shares rose 10% after a Bloomberg report that the company is exploring a potential sale.

On the losing side, 10X Genomics ( TXG ) shares slumped 27% after the company reported preliminary Q3 sales that trailed analysts' projections.